Fig. 3
From: CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma
Silencing of CCAT2 inhibits PDAC tumor growth in vivo. Female nude mice (n = 5/group) was implanted with si-CCAT2-treated or Scramble-treated PANC-1 xenografts and tumor growth was monitored continuously for 4 weeks. a CCAT2 expression in xenograft PDAC tumors was compared between si-CCAT2 and Scramble groups (P = 0.008) when tumors were harvested 4 weeks after PANC-1 cell injection. b Tumor volume was recorded once per week after PANC-1 cells injection. *P < 0.05. c Representative images of PDAC xenograft tumors from each group at the time of study termination (week 4). d Tumor weight were compared between si-CCAT2-treated or Scramble-treated groups (P = 0.005)